← Back to patent-cliff list
CAS 17193-43-0
Ethyl O-methyl-L-tyrosinate
Codes: Tamsulosin Hydrochloride-071
Application context (from source-drug indications)
Erectile dysfunctionTadalafil/TamsulosinBenign prostatic hyperplasiaTadalafil/TamsulosinLower urinary tract symptomsSolifenacin Succinate/Tamsulosin HydrochlorideBenign prostatic hyperplasiaSolifenacin Succinate/Tamsulosin HydrochlorideOveractive bladderSolifenacin Succinate/Tamsulosin HydrochlorideDrug-related adverse effects and reactionsSolifenacin Succinate/Tamsulosin HydrochlorideBladder neck obstructionSolifenacin Succinate/Tamsulosin HydrochlorideBenign prostatic hyperplasiaDutasteride/Tamsulosin HydrochlorideBenign prostatic hyperplasiaTamsulosin HydrochlorideUrinary tract infectionTamsulosin HydrochlorideUrinary retentionTamsulosin HydrochlorideInguinal herniaTamsulosin HydrochlorideVoiding dysfunctionTamsulosin HydrochlorideLower urinary tract symptomsTamsulosin Hydrochloride
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Tadalafil/Tamsulosin | Tier C — Watch / trade | - |
| Solifenacin Succinate/Tamsulosin Hydrochloride | Tier C — Watch / trade | - |
| Dutasteride/Tamsulosin Hydrochloride | Tier C — Watch / trade | - |
| Tamsulosin Hydrochloride | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
4-Methoxybenzaldehyde→2-Acetamidoacetic acid→(4E)-4-(4-Methoxybenzylidene)-2-methyl-1,3-oxazol-5(4H)-one→(2E)-2-(Acetylamino)-3-(4-methoxyphenyl)prop-2-enoic acid→N-Acetyl-O-methyl-L-tyrosine→O-Methyl-L-tyrosine→Ethyl O-methyl-L-tyrosinate→Ethyl N-[(benzyloxy)carbonyl]-O-methyl-L-tyrosinate→Benzyl [(2S)-1-hydroxy-3-(4-methoxyphenyl)propan-2-yl]carbamate→(2S)-2-[[(Benzyloxy)carbonyl]amino]-3-(4-methoxyphenyl)propyl 4-methylbenzenesulfonate→Benzyl [(2S)-1-iodo-3-(4-methoxyphenyl)propan-2-yl]carbamate→Benzyl [(2R)-1-(4-methoxyphenyl)propan-2-yl]carbamate
4-Methoxybenzaldehyde→2-Acetamidoacetic acid→(4E)-4-(4-Methoxybenzylidene)-2-methyl-1,3-oxazol-5(4H)-one→(2E)-2-(Acetylamino)-3-(4-methoxyphenyl)prop-2-enoic acid→N-Acetyl-O-methyl-L-tyrosine→O-Methyl-L-tyrosine→Ethyl O-methyl-L-tyrosinate→Ethyl N-[(benzyloxy)carbonyl]-O-methyl-L-tyrosinate→Benzyl [(2S)-1-hydroxy-3-(4-methoxyphenyl)propan-2-yl]carbamate→(2S)-2-[[(Benzyloxy)carbonyl]amino]-3-(4-methoxyphenyl)propyl 4-methylbenzenesulfonate→Benzyl [(2S)-1-iodo-3-(4-methoxyphenyl)propan-2-yl]carbamate→Benzyl [(2R)-1-(4-methoxyphenyl)propan-2-yl]carbamate
4-Methoxybenzaldehyde→2-Acetamidoacetic acid→(4E)-4-(4-Methoxybenzylidene)-2-methyl-1,3-oxazol-5(4H)-one→(2E)-2-(Acetylamino)-3-(4-methoxyphenyl)prop-2-enoic acid→N-Acetyl-O-methyl-L-tyrosine→O-Methyl-L-tyrosine→Ethyl O-methyl-L-tyrosinate→Ethyl N-[(benzyloxy)carbonyl]-O-methyl-L-tyrosinate→Benzyl [(2S)-1-hydroxy-3-(4-methoxyphenyl)propan-2-yl]carbamate→(2S)-2-[[(Benzyloxy)carbonyl]amino]-3-(4-methoxyphenyl)propyl 4-methylbenzenesulfonate→Benzyl [(2S)-1-iodo-3-(4-methoxyphenyl)propan-2-yl]carbamate→Benzyl [(2R)-1-(4-methoxyphenyl)propan-2-yl]carbamate
4-Methoxybenzaldehyde→2-Acetamidoacetic acid→(4E)-4-(4-Methoxybenzylidene)-2-methyl-1,3-oxazol-5(4H)-one→(2E)-2-(Acetylamino)-3-(4-methoxyphenyl)prop-2-enoic acid→N-Acetyl-O-methyl-L-tyrosine→O-Methyl-L-tyrosine→Ethyl O-methyl-L-tyrosinate→Ethyl N-[(benzyloxy)carbonyl]-O-methyl-L-tyrosinate→Benzyl [(2S)-1-hydroxy-3-(4-methoxyphenyl)propan-2-yl]carbamate→(2S)-2-[[(Benzyloxy)carbonyl]amino]-3-(4-methoxyphenyl)propyl 4-methylbenzenesulfonate→Benzyl [(2S)-1-iodo-3-(4-methoxyphenyl)propan-2-yl]carbamate→Benzyl [(2R)-1-(4-methoxyphenyl)propan-2-yl]carbamate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.